Jimenez vows Novartis-wide GMP standard; Catalent expands in Germany;

> "We are committed to ensuring one single high quality standard across Novartis and will invest the necessary resources to achieve this goal in all divisions," said Novartis ($NVS) CEO Joe Jimenez in a financial filing. Story

> Catalent Pharma said it is expanding its Schorndorf, Germany facility, adding R&D and commercial-scale fluid bed technology, OptiMelt hot-melt extrusion and cGMP compliance upgrades. Release

> CMO Patheon has elevated Antonella Mancuso to president, global commercial operations and chief manufacturing officer. Release

> The FDA has added Tromethamine, made by Hospira ($HSP), to the list of resolved drug shortages. Listing.

> Supply chain industry group GS1 is readying a pilot project in Thailand for use of bar codes on nutritional ingredients. Story

> The DEA has registered AMPAC Fine Chemicals as a manufacturer of controlled substances. Article

> Washington state pharmacies were raided by federal officials on suspicion they were reselling drugs that had been returned. Story

> Thin Film Electronics and PST Sensors will collaborate to develop a printed sensor system that monitors the temperature of in-transit pharmaceuticals and foods. Article